Ziegler Capital Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.92M Buy
73,007
+31,661
+77% +$2.61M 0.07% 219
2023
Q4
$3.26M Sell
41,346
-52,444
-56% -$3.16M 0.15% 167
2023
Q3
$5.13M Sell
93,790
-12,290
-12% -$885K 0.21% 164
2023
Q2
$8.91M Buy
106,080
+35,990
+51% +$2.76M 0.34% 104
2023
Q1
$5.31M Buy
70,090
+64,457
+1,144% +$4.46M 0.21% 164
2022
Q4
$348K Sell
5,633
-6
-0.1% -$319 0.01% 363
2022
Q3
$235K Buy
+5,639
New +$245K 0.01% 378

Other funds holding TMDX

Ziegler Capital Management's TMDX Position: Q1 2024 in Review

Ziegler Capital Management increased its Transmedics (TMDX) stake by 77% in Q1 2024, buying an estimated $2.61M and bringing the position to 73,007 shares worth $1.92M. The position accounts for 0.07% of the portfolio, ranked #219.

Ziegler Capital Management first reported a position in TMDX in Q3 2022 and has held it in 7 quarters since. The position peaked at $8.91M in Q2 2023. 263 funds tracked by Wall St. Rank hold TMDX as of Q1 2024.

  • Ziegler Capital Management held 73,007 shares of Transmedics worth $1.92M as of Q1 2024.
  • Ziegler Capital Management bought 31,661 Transmedics shares in Q1 2024, an estimated $2.61M.
  • Transmedics made up 0.07% of Ziegler Capital Management's portfolio in Q1 2024, its #219 holding.
  • Ziegler Capital Management first reported a position in Transmedics in Q3 2022 and has held it in 7 quarters since.
  • Ziegler Capital Management's Transmedics position peaked at $8.91M in Q2 2023.
  • 263 funds tracked by Wall St. Rank held Transmedics as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.